Citations for
1MPS2, IDS
Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).
Martin R, Beck M, Eng C, Giugliani R, Harmatz P, Mu–oz V, Muenzer J.
Pediatrics 121(2):e377-86. Review. 2008
2MPS2, IDS
Initial report from the Hunter Outcome Survey.
Wraith JE, Beck M, Giugliani R, Clarke J, Martin R, Muenzer J; on behalf of the HOS Investigators.
Genet Med enet Med. 2008 Jun 18. [Epub ahead of print] 2008
3MPS2, IDS
Mucopolysaccharidosis type II: an update on mutation spectrum.
Froissart R, Da Silva IM, Maire I.
Acta Paediatr Suppl 96(455):71-7. Review. 2007
4IDS, MPS2
Characterization of a novel p.S305P and a known c.1006+5G>C splice site mutation in human iduronate-2-sulfatase associated with mucopolysaccharidosis type II.
Chang JH, Lee-Chen GJ, Lin SP, Chuang CK.
Clin Chim Acta 384(1-2):167-70. Epub 2007 Jun 28. No abstract available. 2007
5MPS2, IDS
Expression studies of mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II).
Chang JH, Lin SP, Lin SC, Tseng KL, Li CL, Chuang CK, Lee-Chen GJ.
Hum Genet 116(3):160-6. Epub 2004 Dec 22. 2005
6MPS2, IDS
Mucopolysaccharidosis type II in females: case report and review of literature.
Tuschl K, Gal A, Paschke E, Kircher S, Bodamer OA.
Pediatr Neurol 32(4):270-2. Review. 2005
7IDS, MPS2
Analysis of normal and mutant iduronate-2-sulphatase conformation.
Parkinson-Lawrence E, Turner C, Hopwood J, Brooks D.
Biochem J 386(Pt 2):395-400. 2005
8IDS, MPS2
An Alu-mediated rearrangement as cause of exon skipping in Hunter disease.
Ricci V, Regis S, Di Duca M, Filocamo M.
Hum Genet 112(4):419-25. Epub 2003 Feb 11. 2003
9IDS, IDSCR, MPS2
Analysis of a 43.6 kb deletion in a patient with Hunter syndrome (MPSII): identification of a fusion transcript including sequences from the gene W and the IDS gene.
Lagerstedt K, Carlberg BM, Karimi-Nejad R, Kleijer WJ, Bondeson ML.
Hum Mutat 15(4):324-31. 2000
10IDS, MPS2
Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome).
Li P, Bellows AB, Thompson JN.
J Med Genet 36 : 21-27. 1999
11IDS, MPS2
Mucopolysaccharidosis type II: identification of six novel mutations in Italian patients.
Villani GR, Balzano N, Grosso M, Salvatore F, Izzo P, Di Natale P.
Hum Mutat 10(1):71-5. 1997
12IDS, MPS2
Characterization of iduronate sulphatase mutants affecting N-glycosylation sites and the cysteine-84 residue.
Millat G, Froissart R, Maire I, Bozon D.
Biochem J 326 ( Pt 1):243-7. 1997
13IDS, MPS2
Mutations in the iduronate-2-sulfatase gene in five Norwegians with Hunter syndrome.
Olsen TC, et al.
Hum Genet 97 : 198-203. 1996
14IDS, MPS2
Two new nonsense mutations (Q80X; Q389X) in patients with severe Hunter syndrome (mucopolysaccharidosis type II).
Carrozzo R, et al.
Hum Mutat 7 : 184. 1996
15IDS, FMR1, MPS2
A 5-megabase familial deletion removes the IDS and FMR-1 genes in a male Hunter patient
Birot AM, et al.
Hum Mutat 7 : 266-268. 1996
16IDS, MPS2
Mutation analysis in 20 patients with Hunter disease.
Leistner Goldenfum S, et al.
Hum Mutat 7 : 76-78. 1996
17IDS, MPS2
Mucopolysaccharidosis type II (Hunter syndrome) : mutation hot spots in the iduronate-2-sulfatase gene.
Rathmann M, et al.
Am J Hum Genet 59 : 1202-1209. 1996
18IDS, MPS2
Mutations of the iduronate-2-Sulfatase gene in 12 Polish patients with mucopolysaccharidosis type II (Hunter syndrome).
Popowska E, et al.
Hum Mutat 5 : 97-100. 1995
19IDS, MPS2
Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted interpretation : toward mutation mapping of the iduronate-2-sulfatase gene.
Jonsson JJ, et al.
Am J Hum Genet 56 : 597-607. 1995
20IDS, IDSP1, MPS2
Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome.
Bondeson ML, et al.
Hum Mol Genet 4 : 615-621. 1995
21IDS, MPS2
Mucopolysaccharidosis type II (Hunter disease) : identification and characterization of eight point mutations in the iduronate-2-sulfatase gene in Japanese patients.
Sukegawa K, et al.
Hum Mutat 6 : 136-143. 1995
22IDS, MPS2
Mutations of the Iduronate-2-Sulfatase (IDS) gene in patients with Hunter syndrome (mucopolysaccharidosis II).
Schršder W, et al.
Hum Mutat 4 : 128-131. 1994
23MPS2
Carrier detection of Hunter syndrome (MPS II) by biochemical and DNA techniques in families at risk.
Schršder W, et al.
J Med Genet 30 : 210-213. 1993
24MPS2, IDS
Molecular basis of mucopolysaccharidosis type II : mutations in the iduronate-2-sulphatase gene.
Hopwood JJ, et al.
Hum Mutat 2 : 435-442. 1993
25IDS, MPS2
Hunter syndrome : gene deletions and rearrangements.
Froissart R, et al.
Hum Mutat 2 : 138-140. 1993
26MPS2, IDS
An 8-bp deletion in exon B of the iduronate-2-sulphate sulphatase gene in a case of Hunter disease.
Goldenfum S, et al.
Hum Mol Genet 2 : 1063-1065. 1993
27IDS, MPS2
Caveat to genotype-phenotype correlation in mucopolysaccharidosis type II : discordant clinical severity of R468W and R468Q mutations of the iduronate-2-sulfatase gene.
Whitley CB, et al.
Hum Mutat 2 : 235-237. 1993
28IDS, MPS2
The iduronate sulfatase gene : isolation of a 1.2-Mb YAC contig spanning the entire gene and identification of heterogeneous deletions in patients with Hunter syndrome.
Palmieri G, et al.
Genomics 12 : 52-57. 1992
29IDS, MPS2
Structural gene aberrations in mucopolysaccharidosis II (Hunter).
Wehnert M, et al.
Hum Genet 89 : 430-432. 1992
30IDS, MPS2
Detection of point mutations and a gross deletion in six Hunter syndrome patients.
Flomen RH, et al.
Genomics 13 : 543-550. 1992
31IDS, MPS2
Molecular analysis of patients with Hunter syndrome : implication of a region prone to structural alterations within the IDS gene.
SteŽn-Bondeson ML, et al.
Hum Mol Genet 1 : 195-198. 1992
32IDS, MPS2
Mutation R468W of the iduronate-2-sulfatase gene in mild Hunter syndrome (mucopolysaccharidosis type II) confirmed by in vitro mutagenesis and expression.
Crotty PL, et al.
Hum Mol Genet 1 : 755-757. 1992
33MPS2
Female twin with Hunter disease due to nonrandom inactivation of the X-chromosome : a consequence of twinning.
Winchester B, et al.
Am J Med Genet 44 : 834-838. 1992
34IDS, MPS2
Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome.
Clarke JTR, et al.
Am J Hum Genet 51 : 316-322. 1992
35IDS, MPS2
The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulphatase gene (mucopolysaccharidosis II - Hunter syndrome).
Wraith JE, et al.
Hum Genet 87 : 205-206. 1991
36IDS, MPS2
Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl.
Clarke JTR, et al.
Am J Hum Genet 49 : 289-297. 1991
37IDS, MPS2
Molecular aberration in patients of iduronate-2-sulphate-sulphatase defect (MPS II, Hunter).
Herrmann FH, et al.
(HGM11) Cytogenet Cell Genet 58 : 2066. 1991
38IDS, MPS2
Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome.
Wilson PJ, et al.
Hum Genet 86 : 505-508. 1991
39IDS, MPS2
Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.
Wilson PJ, et al.
Proc Natl Acad Sci U S A 87 : 8531-8535. 1990
40IDS, MPS2
Genetics of Hunter syndrome : carrier detection, new mutations, segregation and linkage analysis.
Chase DS, et al.
Ann Hum Genet 50 : 349-360. 1986
41IDS, MPS2
Hunter's disease in a girl: association with X:5 chromosomal translocation disrupting the Hunter gene.
Mossman LM, et al.
Arch Dis Child 58 : 911-915. 1983